Showing results (131-140 of 3,099) with videos related to
Sort By:
Pageof 310
Genes, Chromosomes & Cancer|January 19, 1999
der(16)t(1;16)/der(1;16) in breast cancer detected by fluorescence in situ hybridization is an indicator of better patient prognosisH Tsuda, T Takarabe, T Fukutomi, et al.Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1990
Expression of ras p21 protein by thymomaK Mukai, Y Sato, S Hirohashi, et al.International Journal of Cancer|December 1, 1994
Pathogenetic significance of p53 and c-Ki-ras gene mutations and human papillomavirus DNA integration in adenocarcinoma of the uterine cervix and uterine isthmusK Jiko, H Tsuda, S Sato, et al.Journal of the National Cancer Institute|June 1, 1984
Distribution of blood group antigens A, B, H, and I(Ma) in mucus-producing adenocarcinoma of human lungS Hirohashi, Y Ino, T Kodama, et al.Gan|June 1, 1984
Monoclonal antibody reactive with the sialyl-sugar residue of a high molecular weight glycoprotein in sera of cancer patientsS Hirohashi, M Watanabe, Y Shimosato, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1994
[Advances in pathobiological research on lung carcinoma]M NoguchiEuropean Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 15, 2007
Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancerM NoguchiThe British Journal of Surgery|February 20, 2002
Sentinel lymph node biopsy and breast cancerM NoguchiThe British Journal of Surgery|November 26, 2002
Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodesM NoguchiJournal of Surgical Oncology|February 27, 2001
Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patientsM NoguchiPageof 310